Mechanical strength and biocompatibility of bredigite (Ca7MgSi4O16) tissue-engineering scaffolds modified by aliphatic polyester coatings
Source abstract
Abstract
Bredigite (Ca7MgSi4O16) is a bioceramic with excellent bioactivity and bioresorbability; nonetheless, its inadequate mechanical strength and biocompatibility limit its tissueengineering application. In this research, interconnected porous bredigite scaffolds were fabricated by sol-gel, sacrificial sponge replica and sintering processes for bone tissue engineering. In order to improve their strength and cytocompatibility, the scaffolds were coated with poly(lactic-co-glycolic acid) (PLGA) via immersion in acetone-based solutions containing different concentrations (5, 10 and 15% w/v) of the polymer. Based on the results, the PLGA coatings to 10% do not suppress the porosity characteristics of the scaffolds appropriate for tissue engineering. It was also found that the polymeric coatings significantly enhance the compressive strength of the ceramic scaffolds, where this alteration is improved by increasing the PLGA concentration of the coating solution. In addition, the viability of stem cells on the bredigite scaffolds are improved by using the PLGA coatings, with the optimal concentration of 10% PLGA according to MTT and cell attachment studies.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Dental Implant Techniques and Outcomes · Dental materials and restorations
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (41)
Show source-provided references
1. Artificial scaffolds for peripheral nerve reconstruction10.1016/S0074-7742(09)87009-8 ↗
2. Limitations of autograft and allograft: new synthetic solutions10.3928/0147-7447-20020502-04 ↗
3. Biomaterials & scaffolds for tissue engineering10.1016/S1369-7021(11)70058-X ↗
4. Recent advances in bone tissue engineering scaffolds10.1016/j.tibtech.2012.07.005 ↗
5. Three-dimensional scaffolds for tissue engineering applications: role of porosity and pore size10.1089/ten.teb.2012.0437 ↗
6. Third-generation biomedical materials10.1126/science.1067404 ↗
7. Mechanical evaluation of calcium-zirconium-silicate (baghdadite) obtained by a direct solid-state synthesis route10.1016/j.jmbbm.2014.02.021 ↗
8. A novel bioactive porous bredigite (Ca 7 MgSi 4 O 16) scaffold with biomimetic apatite layer for bone tissue engineering10.1007/s10856-006-0083-0 ↗
9. Gene‐expression profiling of human osteoblasts following treatment with the ionic products of Bioglass® 45S5 dissolution10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.0.CO;2-D ↗
10. Evidence for parathyroid failure in magnesium deficiency10.1126/science.177.4049.606 ↗
11. Metabolic alkalosis10.1681/ASN.V112369 ↗
12. Stimulatory effects of the ionic products from Ca–Mg–Si bioceramics on both osteogenesis and angiogenesis in vitro10.1016/j.actbio.2013.04.024 ↗
13. The effect of poly (lactic-co-glycolic acid)(PLGA) coating on the mechanical, biodegradable, bioactive properties and drug release of porous calcium silicate scaffolds
14. The influences of poly (lactic-co-glycolic acid)(PLGA) coating on the biodegradability, bioactivity, and biocompatibility of calcium silicate bioceramics10.1007/s10853-011-5416-9 ↗
15. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers10.1016/0142-9612(96)85754-1 ↗
16. Bioresorbability and biocompatibility of aliphatic polyesters10.1007/BF00701240 ↗
17. Study on the biocompatibility and degradation behavior of polyl (l-lactide-co-glycolide) in vitro and in vivo
18. Ducheyne · 2015
19. In vitro degradation rate of apatitic calcium phosphate cement with incorporated PLGA microspheres10.1016/j.actbio.2011.05.036 ↗
20. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier10.3390/polym3031377 ↗
21. Synthesis and in vitro bioactivity of bredigite powders10.1177/0885328206062360 ↗
22. Strontium doping into diopside tissue engineering scaffolds10.1016/j.ceramint.2019.02.067 ↗
23. Co-incorporation of strontium and fluorine into diopside scaffolds: bioactivity, biodegradation and cytocompatibility evaluations10.1016/j.msec.2019.109752 ↗
24. Modified Scherrer equation to estimate more accurately nano-crystallite size using XRD10.4236/wjnse.2012.23020 ↗
25. Mechanical and cytotoxicity evaluation of nanostructured hydroxyapatite-bredigite scaffolds for bone regeneration10.1016/j.msec.2016.06.030 ↗
26. Preparation and structural characterization of bioactive bredigite (Ca7MgSi4O16) nanopowder10.1016/j.jallcom.2017.10.132 ↗
27. Enhanced mechanical properties of thermosensitive chitosan hydrogel by silk fibers for cartilage tissue engineering10.1016/j.msec.2013.07.043 ↗
28. Inorganic-salt coprecipitation synthesis, fluoride-doping, bioactivity and physiological pH buffering evaluations of bredigite10.1016/j.ceramint.2020.02.107 ↗
29. Recent biomedical applications and patents on biodegradable polymer-PLGA
30. Electrospinning of PLGA/gelatin randomly-oriented and aligned nanofibers as potential scaffold in tissue engineering10.1016/j.msec.2010.06.018 ↗
31. Encapsulation and release of doxycycline from electrospray-generated PLGA microspheres: effect of polymer end groups10.1016/j.ijpharm.2019.04.023 ↗
32. Factorial design formulation optimization and in vitro characterization of curcumin-loaded PLGA nanoparticles for colon delivery10.1016/j.jddst.2016.01.007 ↗
33. O'Shea · 2010 · 517
34. Magnesium-containing bioactive polycrystalline silicate-based ceramics and glass-ceramics for biomedical applications10.1016/j.cossms.2014.02.004 ↗
35. Fabrication of bioactive porous bredigite (Ca7MgSi4O16) scaffold via space holder method10.3139/146.111597 ↗
36. Bone compressive strength: the influence of density and strain rate10.1126/science.996549 ↗
37. Novel hydroxyapatite ceramics with an interconnective porous structure exhibit superior osteoconduction in vivo10.1002/jbm.1222 ↗
38. Calcium and cell death mechanisms: a perspective from the cell death community10.1016/j.ceca.2011.03.003 ↗
39. Cultivation of mammalian cells as aggregates in bioreactors: effect of calcium concentration of spatial distribution of viability10.1002/bit.260410203 ↗
40. Hutmacher · 2000 · 175
41. Degradation, bioactivity, and cytocompatibility of diopside, akermanite, and bredigite ceramics10.1002/jbm.b.30779 ↗